Transthyroxin Amyloidosis Cardiomyopathy
1 clinical trials · Condition
◉ Watch Transthyroxin Amyloidosis Cardiomyopathy
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Intravenous YOLT-201 for Transthyretin Amyloidosis Cardiomyopathy (NCT06082050) | Zhejiang University | 2023-11-02 |
Track Transthyroxin Amyloidosis Cardiomyopathy automatically
Every clearance here is in the API, with alerts when new ones post.